Published in Adv Genet on January 01, 2010
Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell (2012) 3.65
DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell (2012) 2.45
Methylation markers of early-stage non-small cell lung cancer. PLoS One (2012) 1.65
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett (2012) 1.36
DNA methylation and cancer diagnosis. Int J Mol Sci (2013) 1.18
Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics (2013) 1.11
DNA methylation biomarkers: cancer and beyond. Genes (Basel) (2014) 1.11
Functional DNA demethylation is accompanied by chromatin accessibility. Nucleic Acids Res (2013) 1.09
Method to detect differentially methylated loci with case-control designs using Illumina arrays. Genet Epidemiol (2011) 1.07
Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb) (2015) 1.04
Interplay between Epigenetics and Genetics in Cancer. Genomics Inform (2013) 1.03
Pan-cancer patterns of DNA methylation. Genome Med (2014) 1.02
Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. Sci Rep (2015) 1.02
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics (2012) 0.98
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol (2015) 0.97
Environmental toxicants, epigenetics, and cancer. Adv Exp Med Biol (2013) 0.94
The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene (2012) 0.94
Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances. Genes Chromosomes Cancer (2011) 0.92
Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme. Cancer Gene Ther (2014) 0.91
Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma. BMC Syst Biol (2013) 0.87
Competing views on cancer. J Biosci (2014) 0.86
Potential role of a navigator gene NAV3 in colorectal cancer. Br J Cancer (2011) 0.85
Epigenetic pathways and glioblastoma treatment. Epigenetics (2013) 0.85
Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors. Cancer Res (2014) 0.84
Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer (2013) 0.83
An integrated approach to uncover driver genes in breast cancer methylation genomes. PLoS One (2013) 0.81
Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression. Cancer Microenviron (2012) 0.81
Dose- and time-dependent epigenetic changes in the livers of Fisher 344 rats exposed to furan. Toxicol Sci (2014) 0.81
Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype. Epigenetics Chromatin (2015) 0.81
Identification of collaborative driver pathways in breast cancer. BMC Genomics (2014) 0.81
A cross-sectional study of global DNA methylation and risk of colorectal adenoma. BMC Cancer (2014) 0.80
MIRA-seq for DNA methylation analysis of CpG islands. Epigenomics (2015) 0.80
Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer. PLoS One (2015) 0.80
Genome-wide promoter methylome of small renal masses. PLoS One (2013) 0.80
Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Epigenetics (2014) 0.80
New concepts in breast cancer genomics and genetics. Breast Cancer Res (2014) 0.79
Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data. Nucleic Acids Res (2015) 0.79
Human induced pluripotent stem cells from basic research to potential clinical applications in cancer. Biomed Res Int (2013) 0.78
Analysis of the coding sequence and expression of the coiled-coil α-helical rod protein 1 gene in normal and neoplastic epithelial cervical cells. Int J Mol Med (2012) 0.78
Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer (2010) 0.78
Epigenomic biomonitors: global DNA hypomethylation as a biodosimeter of life-long environmental exposures. Epigenomics (2011) 0.77
Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer. Epigenetics (2016) 0.77
Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis. Virol J (2014) 0.77
Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients. Saudi J Gastroenterol (2016) 0.76
Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma. Biomed Res Int (2016) 0.75
The DNA methylation landscape of human melanoma. Genomics (2015) 0.75
Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia. Oncol Lett (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Inflammation and cancer. Nature (2002) 53.78
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A (1992) 29.51
Control of developmental regulators by Polycomb in human embryonic stem cells. Cell (2006) 28.21
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30
Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev (2006) 14.36
The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol (2009) 11.18
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature (2007) 11.14
Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet (2010) 10.71
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47
Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis. J Mol Biol (1978) 9.89
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J (2003) 9.55
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45
Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86
Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res (2008) 8.62
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature (2007) 8.33
High-throughput DNA methylation profiling using universal bead arrays. Genome Res (2006) 8.05
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61
Stem cells and cancer; the polycomb connection. Cell (2004) 7.43
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell (2009) 7.39
A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A (2008) 7.14
DNA methylation in cancer: too much, but also too little. Oncogene (2002) 6.96
Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Genome Res (2006) 6.75
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71
Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res (2006) 5.99
The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer (2007) 5.78
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell (2002) 5.23
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet (2008) 5.08
Inflammation, a key event in cancer development. Mol Cancer Res (2006) 5.03
Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet (2006) 4.97
Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res (2009) 4.92
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A (2005) 4.57
Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol (2007) 4.40
Purification of CpG islands using a methylated DNA binding column. Nat Genet (1994) 4.31
Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods (2010) 4.30
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet (1999) 4.23
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res (2008) 4.19
Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 4.16
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res (2008) 3.81
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res (2006) 3.66
Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer (2002) 3.53
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One (2009) 3.33
Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer (2005) 3.27
Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet (1999) 3.26
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol (2008) 3.18
Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res (2010) 2.99
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91
Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res (2001) 2.80
Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res (2002) 2.71
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 2.69
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res (2005) 2.67
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2004) 2.60
Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res (2001) 2.60
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res (2003) 2.41
Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther (2008) 2.38
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell (2003) 2.38
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology (2006) 2.33
Mutational spectra of human cancer. Hum Genet (2009) 2.26
Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A (2003) 2.25
Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol (2006) 2.24
Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab Invest (2005) 2.23
Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res (2008) 2.22
A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics (2009) 2.21
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics (2010) 2.19
Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs. Genome Res (2007) 2.16
Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res (2009) 2.13
Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci U S A (2005) 2.11
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A (2007) 2.10
Profiling DNA methylation patterns using genomic tiling microarrays. Nat Methods (2005) 2.10
High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res (2007) 2.09
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest (2009) 2.09
Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res (2008) 2.08
A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci U S A (1991) 2.08
Tumor susceptibility of Rassf1a knockout mice. Cancer Res (2005) 2.03
Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res (2009) 2.03
Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer (2003) 2.01
DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res (2007) 1.96
Polycomb group proteins in cell cycle progression and cancer. Cell Cycle (2004) 1.94
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res (2002) 1.91
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature (2011) 6.73
Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci U S A (2011) 5.45
Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res (2010) 4.79
A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci U S A (2009) 4.72
MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res (2006) 3.66
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91
Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res (2011) 2.53
The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta (2009) 2.50
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res (2011) 2.36
GADD45A does not promote DNA demethylation. PLoS Genet (2008) 2.36
A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell (2008) 2.28
Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab Invest (2005) 2.23
Repair of methylation damage in DNA and RNA by mammalian AlkB homologues. J Biol Chem (2005) 2.19
Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep (2013) 2.10
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A (2007) 2.10
The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem (2006) 2.10
Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res (2008) 2.08
Tumor susceptibility of Rassf1a knockout mice. Cancer Res (2005) 2.03
Insulin gene expression is regulated by DNA methylation. PLoS One (2009) 1.97
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene (2002) 1.96
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol (2007) 1.91
Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther (2005) 1.67
The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell (2005) 1.58
CpG island hypermethylation in human astrocytomas. Cancer Res (2010) 1.57
Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene (2003) 1.54
Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS One (2011) 1.50
Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst (2003) 1.48
Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res (2003) 1.48
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog (2007) 1.44
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res (2009) 1.43
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology (2009) 1.43
MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex. J Biol Chem (2004) 1.41
The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. Cell Cycle (2005) 1.37
The MIRA method for DNA methylation analysis. Methods Mol Biol (2009) 1.35
DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35
Epigenetic control of female puberty. Nat Neurosci (2013) 1.34
Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol (2015) 1.30
DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). Methods (2010) 1.30
RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene (2002) 1.29
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene (2003) 1.27
Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene (2002) 1.23
Microcephalin encodes a centrosomal protein. Cell Cycle (2006) 1.21
Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res (2002) 1.21
The role of DNA polymerase eta in UV mutational spectra. DNA Repair (Amst) (2005) 1.20
Second-hand smoke and human lung cancer. Lancet Oncol (2008) 1.17
Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene (2003) 1.15
DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A (2005) 1.15
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res (2002) 1.15
Aging and DNA methylation. BMC Biol (2015) 1.15
A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer (2010) 1.14
Human thymine DNA glycosylase (TDG) and methyl-CpG-binding protein 4 (MBD4) excise thymine glycol (Tg) from a Tg:G mispair. Nucleic Acids Res (2003) 1.14
Tet-mediated formation of 5-hydroxymethylcytosine in RNA. J Am Chem Soc (2014) 1.14
The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. J Biol Chem (2004) 1.13
Human RIF1 encodes an anti-apoptotic factor required for DNA repair. Carcinogenesis (2009) 1.12
Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis. Carcinogenesis (2005) 1.11
Chromosome-wide analysis of parental allele-specific chromatin and DNA methylation. Mol Cell Biol (2011) 1.11
Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res (2008) 1.10
A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis (2007) 1.10
Translesion synthesis of 7,8-dihydro-8-oxo-2'-deoxyguanosine by DNA polymerase eta in vivo. Mutat Res (2008) 1.09
The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem (2011) 1.09
Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res (2005) 1.09
Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol (2011) 1.08
Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J Biol Chem (2003) 1.08
CTCF-dependent chromatin bias constitutes transient epigenetic memory of the mother at the H19-Igf2 imprinting control region in prospermatogonia. PLoS Genet (2010) 1.07
Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Oncogene (2004) 1.07
Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer (2010) 1.07
53BP1 is a positive regulator of the BRCA1 promoter. Cell Cycle (2005) 1.06
Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing. PLoS One (2010) 1.06
G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells. Biochemistry (2004) 1.05
A methylation profile of in vitro immortalized human cell lines. Int J Oncol (2005) 1.04
Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res (2003) 1.04
Fine tuning of globin gene expression by DNA methylation. PLoS One (2006) 1.04
MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor. Genomics (2002) 1.04
The role of DNA polymerase iota in UV mutational spectra. Mutat Res (2006) 0.99
Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res (2006) 0.99
Methods for genome-wide analysis of DNA methylation in intestinal tumors. Mutat Res (2009) 0.99
Fen1 mutations that specifically disrupt its interaction with PCNA cause aneuploidy-associated cancer. Cell Res (2011) 0.98
Transcription-dependent cytosine deamination is a novel mechanism in ultraviolet light-induced mutagenesis. Curr Biol (2009) 0.98
Parent-of-origin-specific binding of nuclear hormone receptor complexes in the H19-Igf2 imprinting control region. Mol Cell Biol (2004) 0.98
DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxides in mouse cells. Cancer Res (2004) 0.98
Simulated sunlight and benzo[a]pyrene diol epoxide induced mutagenesis in the human p53 gene evaluated by the yeast functional assay: lack of correspondence to tumor mutation spectra. Carcinogenesis (2003) 0.96
Characterization of the 3' --> 5' exonuclease activity found in human nucleoside diphosphate kinase 1 (NDK1) and several of its homologues. Biochemistry (2005) 0.96
MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing. J Biol Chem (2005) 0.95
Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression. Nat Commun (2012) 0.95
Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing. FASEB J (2010) 0.94
Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C. Proc Natl Acad Sci U S A (2007) 0.94
Effects of endocrine disruptors on imprinted gene expression in the mouse embryo. Epigenetics (2011) 0.93
The mysterious presence of a 5-methylcytosine oxidase in the Drosophila genome: possible explanations. Cell Cycle (2013) 0.93
Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation (2009) 0.92
Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J (2008) 0.91
Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse. Dev Dyn (2008) 0.90
Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res (2007) 0.90
Similar mutagenicity of photoactivated porphyrins and ultraviolet A radiation in mouse embryonic fibroblasts: involvement of oxidative DNA lesions in mutagenesis. Biochemistry (2004) 0.88
In vivo assays for transcription-coupled repair. Methods Enzymol (2006) 0.88
CDK5RAP2 is required for spindle checkpoint function. Cell Cycle (2009) 0.88
Peroxyl radical mediated oxidative DNA base damage: implications for lipid peroxidation induced mutagenesis. Biochemistry (2004) 0.87
Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst (2004) 0.87
The retinitis pigmentosa-mutated RP2 protein exhibits exonuclease activity and translocates to the nucleus in response to DNA damage. Exp Cell Res (2006) 0.86